Track topics on Twitter Track topics that are important to you
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. Epitomics, Inc. (www.epitomics.com) is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.
Recently, Epitomics was issued two important industry-changing patents that go a long way towards solidifying the company’s position in the growing monoclonal antibody marketplace. To summarize the patents:
- Epitomics was issued patent no. 7,429,487, which covers the next generation of cells for producing rabbit monoclonal antibodies and further establishes Epitomics’ unique position as *the* rabbit monoclonal antibody company.
- Epitomics was issued patent no. 7,431,927 covering a broad grouping of anti-TNF (Tumor Necrosis Factor) antibodies. This potentially industry-changing antibody patent provides a sweeping grant of exclusivity that will broadly cover any antibody that contains the binding region of a particular rabbit TNF-neutralizing antibody, as well as a large number of variant antibodies that contain amino acid substitutions in the antibody’s binding region.
These are just two recent accomplishments – the founders of Epitomics have hundreds of antibody-related inventions to their credit and the company is continually innovating. Below are press releases detailing the two recent patents.
863 Mitten Road Suite 103
United States of America
Phone: (650) 583-6688
Fax: (650) 583-6680
SummaryLysozyme 1,4Nacetylmuramidase is an enzyme that plays an important role in the prevention of bacterial infections. It does this by attacking a specific component of certain bacterial cell walls...
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The company utilizes a...
Apexigen, Inc. is a biopharmaceutical company focused on the discovery and development of best-in-class therapeutic antibodies. Apexigen has exclusive rights to the proprietary antibody technologies ...
Biomol GmbH: Antibodies, Kits, Arrays and other Reagents for Biomedical Research. We offer high quality reagents and outstanding technical service for the products from our partners Ampliqon, Assay De...
We have published hundreds of Epitomics, Inc. news stories on BioPortfolio along with dozens of Epitomics, Inc. Clinical Trials and PubMed Articles about Epitomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epitomics, Inc. Companies in our database. You can also find out about relevant Epitomics, Inc. Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...